Intellectual Property News - Secerna LLP

The Edge Of Exclusivity From Revenue Cliff To Biosimilar Slope

The Edge of Exclusivity: From Revenue Cliff to Biosimilar Slope

News 05/05/2026

As we move through 2026 towards 2030, the pharmaceutical industry is no longer approaching the ‘super cliff’ but has already stepped off the edge and is part way down it.

Read more

Secerna Interior Shots September 2024 031

News, Careers 25/11/2025

Launch Your Career as a Trainee Patent Attorney (Physics/ICT/Electronics)

Secerna Website Images 2025 (22)

News 24/11/2025

Contrasting Patent Rulings: Apple Secures Appeal Win and Faces $634 Million Verdict

Getty Images V Stability AI

Industry news, News 12/11/2025

Getty Images v Stability AI: Victory for AI Platform in landmark High Court ruling

The Critical Timing Of IP Protection

News 11/11/2025

The Critical Timing of Intellectual Property (IP) Protection

IPO Image Istock (1)

Industry news, News 10/11/2025

UK IPO Fees Set to Rise in 2026: Time to Review Your IP Strategy

Huw And John Biotech & Beers

Events, News 30/10/2025

Meet Secerna at Biotech & Beers 2025 in Newcastle

The Art And Science Of Fireworks A Celebration In The Sky

Industry news, News 30/10/2025

Patents and Innovations in Fireworks: A Celebration in the Sky

Untitled Design (30)

Events, News 20/10/2025

Triumph at Sea: Secerna LLP Hails Seas the Day's Historic Pacific Crossing

Choosing Between Patents And Trade Secrets In Early Stage Drug Development (1)

News, ELRIG 16/10/2025

Patents vs. Trade Secrets in Early-Stage Drug Development

1 2 3 4 5 6 7 8 9 10